NAD+ is a coenzyme central to energy metabolism and sirtuin signaling. Its decline with age is one of the most studied features of cellular aging. Precursors such as NMN and NR are investigated as ways to support NAD+ availability and downstream cellular energy production.
This pillar is part of an interconnected system. No single intervention works in isolation — each protocol is considered in the context of the whole organism, informed by peer-reviewed research and individual biomarker data.
Compliance
Content on this site is educational and not medical advice. Hormone therapy (TRT), peptide therapy, and prescription-adjacent protocols require evaluation by a licensed physician. Supplement statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.